HIV Gene Therapy

Gene Therapy Trials To Expand; Preliminary Data Reported

Published in AIDS Weekly, March 10th, 1997

Cell Genesys, Inc., Foster City, California, announced plans to expand clinical studies of its AIDS gene therapy currently in Phase II testing.

The planned studies include an evaluation of a new manufacturing process and a pilot study designed to enhance the detection of antiviral effects in patients receiving antiviral drug therapy. The announcement followed a report of preliminary results from the initial Phase II study of this therapy.

Dr. H. Clifford Lane, U.S. National Institute of Allergy and Infectious Diseases (NIAID), reported these data at the American Association of Asthma, Allergy, and Immunology/Clinical Immunology Society Conference,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1997-03-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry